يعرض 1 - 20 نتائج من 3,433 نتيجة بحث عن '(( significant benefits decrease ) OR ( significant ((sizes decrease) OR (greater decrease)) ))', وقت الاستعلام: 0.37s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4

    Soil partice-size distribution. حسب Yonggang Huang (223155)

    منشور في 2025
    "…When the length of UHMWPE is greater than 9 mm, there is no significant decrease in the free swelling ratio of the reinforced soil (<i>p</i> = 0.165). …"
  5. 5
  6. 6
  7. 7
  8. 8

    Summary map of all contacts with statistically significant SVM classifications. حسب Alexander P. Rockhill (6053618)

    منشور في 2024
    "…<p>The top row presents the proportion of significant SVM clusters. It illustrates what proportions of channels are significant at that time-frequency ranging from 0 to 1. …"
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Statins resulted in smaller neuronal soma size. حسب Shuk C. Tsoi (21192243)

    منشور في 2025
    "…Statin treatment decreased cell sizes in the larger cells more than in the smaller cells as seen in the greater divergence between lines plotted for larger cell somas (bottom panel). …"
  15. 15

    Significant condition. حسب Junxia Zhou (14381598)

    منشور في 2024
    الموضوعات:
  16. 16
  17. 17
  18. 18

    Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization حسب figshare admin karger (2628495)

    منشور في 2025
    "…The prognostic significance of reductions in LV size in hearts with normal baseline LV size remains unclear. …"
  19. 19

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"
  20. 20

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…"